Cidara Therapeutics Inc.
20.86
-0.33 (-1.56%)
At close: Jan 14, 2025, 3:59 PM
21.20
1.63%
Pre-market Jan 15, 2025, 07:35 AM EST

Cidara Therapeutics Inc. Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for CDTX stock have an median target of 33, with a low estimate of 24 and a high estimate of 45. The median target predicts an increase of 58.20% from the current stock price of 20.86.

Analyst Consensus: Buy
Target Low Average Median High
Price $24 $32.2 $33 $45
Change 15.05% 54.36% 58.20% 115.72%

AI Analyst Report

HC Wainwright & Co. has maintained a Buy rating on... Unlock content with Pro Subscription

Updated Nov 11, 2024

Rating Jun 24Aug 24Sep 24Oct 24Nov 24Dec 24
Strong Buy 000001
Buy 131121
Hold 000000
Sell 000000
Strong Sell 000000
Total 1 3 1 1 2 2

Financial Forecast this Year

Revenue This Year
5.03M
from 63.91M
Increased by -92.1%
Revenue Next Year
53.59M
from 5.03M
Increased by 964.6%
EPS This Year
-23.83
from -5.25
Increased by -353.9%
EPS Next Year
-9.58
from -23.83
Increased by 59.8%